about
Improved Auditory Nerve Survival with Nanoengineered Supraparticles for Neurotrophin Delivery into the Deafened CochleaElectroacoustic stimulation: now and into the futureThe sustained-release behavior and in vitro and in vivo transfection of pEGFP-loaded core-shell-structured chitosan-based composite particlesBDNF-TrkB axis regulates migration of the lateral line primordium and modulates the maintenance of mechanoreceptor progenitors.A folate receptor-targeted lipoplex delivering interleukin-15 gene for colon cancer immunotherapy.Neurotrophin Gene Therapy in Deafened Ears with Cochlear Implants: Long-term Effects on Nerve Survival and Functional Measures.Hyaluronic acid pretreatment for Sendai virus-mediated cochlear gene transfer.
P2860
Q28553035-1A9FF504-921D-473F-A6F5-A25DC71263F4Q30367376-3E9AFCD0-9375-4E6F-93A8-7A5609CDAD68Q34415610-E10AA205-DA3D-4143-9914-720D23A9DB28Q35159442-304109E8-77F7-441E-BFDB-A4925E3C9244Q37588429-E04E720A-969C-4C30-BA76-801DB9EE9A48Q38641765-57577EEA-CDFE-472C-84DD-044B167FE48BQ41372707-14E11DA0-A0A8-4E64-A3B4-4549FBB89D74
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Viability of long-term gene therapy in the cochlea.
@en
Viability of long-term gene therapy in the cochlea.
@nl
type
label
Viability of long-term gene therapy in the cochlea.
@en
Viability of long-term gene therapy in the cochlea.
@nl
prefLabel
Viability of long-term gene therapy in the cochlea.
@en
Viability of long-term gene therapy in the cochlea.
@nl
P2860
P50
P356
P1433
P1476
Viability of long-term gene therapy in the cochlea
@en
P2093
Brianna O Flynn
Patrick J Atkinson
P2860
P2888
P356
10.1038/SREP04733
P407
P577
2014-04-22T00:00:00Z